Bayer AG's stock demonstrated modest trading activity on Friday, settling at €21.80 with a marginal decline of 0.3%. Trading within a narrow corridor, the stock fluctuated between €21.76 and €21.94, ...

An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bayer AG's stock exhibited a cautiously positive trend in Wednesday's trading, navigating within a narrow range of €21.28 to €21.77 on XETRA. The trading volume remained substantial with over 2.4 ...

Prior to the Monday afternoon commemoration event, a group of WJC steering committee members, leading Jewish communal ...

The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out ...

The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into Bayer AG's tech activities, including its digital ...

Dhanuka Agritech has acquired international rights for two fungicides from Bayer AG for Rs 165 crore. The acquisition includes rights to Bayer's Melody brand, its sub-brands for Iprovalicarb, and ...

Bayer has signed a new exclusive distribution agreement with UK-based Ecospray to market a biological liquid nematicide ...